Find Your Funding Opportunity
Hereditary Hemorrhagic Telangiectasia (HHT) Center
Hereditary Hemorrhagic Telangiectasia (HHT) Center
Service
|
Source |
Final Application Due Date |
Funding Available
|
Match Required
|
|---|---|---|---|---|
| Health Care |
Federal
HHS |
06-20-2025 | $1.8 M | No Match Required |
-
Service
-
Source
-
Final Application Due Date
-
Funding Available
-
Match Required
Status
- Expected Number of Awards 1
- Opportunity Type Discretionary
-
CFDA
93.110 -- Maternal and Child Health Federal Consolidated Programs
Description
The purpose of the Hereditary Hemorrhagic Telangiectasia (HHT) program is to reduce morbidity and mortality associated with HHT by: 1) expanding access to and coordination of care for HHT patients; and 2) developing a de-identified, aggregate patient data registry to better understand this rare disease and treatment outcomes.
MCHB
Eligibility
- IHE
- Local Government
- Non-Profit
- Other
- State Government
- Tribal Government
Additional Eligibility Information
Public Entities, Institutions of Higher Education, Tribes and Tribal Organizations, For-profit organizations, Small businesses, Nonprofits
Key Date(s)
- July 25, 2024: Forecasted Date
- March 10, 2025: Last Updated Date
- April 21, 2025: Estimated Post Date
- June 20, 2025: Estimated Application Due Date
- September 01, 2025: Estimated Project Start Date